Additionally, platelets acquire PD-L1 from tumor cells through fibronectin 1, integrin α5β1, and GPIbα-dependent mechanisms, creating “tumor-educated” platelets with enhanced prothrombotic potential [61]. Here, FN1 is linked to neoplasm.